We have examined the demographics and long-term to be affected. Familial cases closely resembled those remaining sporadic in both demographics and outcome, outcome of 1044 patients with sporadic and familial multiple sclerosis in a population-based cohort from although onset in the most heavily loaded families was earlier and male/female ratio was greater. The times to London, Ontario. The mean follow-up was 25 years in duration, and by this time most patients had reached the DSS 6, 8 and 10 did not differ significantly when sporadic, familial and familial subgroups were compared. These unambiguous endpoint scores of the Kurtzke disability status scale (DSS), DSS 6, 8 or 10. An affected family results provide no clinical support for viewing familial multiple sclerosis as distinct from the sporadic form. The member was identified in 19.8% of the total population, and this subgroup was further divided arbitrarily into observed recurrence rate for siblings in a strictly defined epidemiological sample was 3.5%, much as projected. the following three groups by the type and number of relatives affected: (i) first degree only; (ii) first degree These results validate the recurrence risks which have previously been derived from age-corrected data for these plus others; (iii) second or third degree. The outcome in these groups was compared with that for those patients first-degree relatives. who, at a mean 25 year follow-up, had no relatives known
Introduction
The cause of multiple sclerosis remains uncertain, although underlie the basis of familial aggregation has had limited success to date. recent evidence has solidified the view that both genetic and environmental factors determine susceptibility (Ebers and Although the specific factors determining susceptibility remain indeterminate, there is certainty that the clinical and Sadovnick, 1994) . There is very strong evidence from the classical tools of genetic epidemiology that familial pathological phenotype is variable in the extreme. There is little reason to be confident that multiple sclerosis represents aggregation is determined by multiple genes. This includes data from twins (Ebers et al., 1986; Sadovnick et al., 1993;  a homogeneous and discrete entity. Even the age of onset can span more than five decades in large population-based Mumford et al., 1994) , adoptees (Ebers et al., 1995) , halfsiblings (Sadovnick et al., 1996) and the offspring of conjugal samples (Weinshenker et al., 1989) . Nevertheless, the difference in disability outcome, which can range from nonpairs (Robertson et al., 1997) . The gradual reduction in risk as one goes from first-to second-to third-degree relatives existent in asymptomatic multiple sclerosis discovered at autopsy to a disease that is fatal in Ͻ12 months, is readily supports early suggestions that multiple sclerosis susceptibility is polygenic (Pratt et al., 1951; demonstrable in multiple sclerosis surveys. It would not be surprising if it were concluded that genes 1982; Ebers, 1983; Ebers and Sadovnick, 1994) . However, the search for specific chromosomal regions or genes which play a role in outcome, although little direct evidence has been put forward to support this view. If multiple sclerosis (ii) 40 patients were found not to have multiple sclerosis. The great majority of the latter represented possible cases in is a heterogeneous group of disorders, the resolution of the problem of susceptibility will be difficult by conventional whom multiple sclerosis was initially thought to be the most likely diagnosis but who proved to have other conditions on methods. The identification of discrete subgroups of multiple sclerosis would have implications both for genetic studies follow-up. (Cottrell et al., 1999a) . This patient population was seen on a more or less yearly and for the understanding of factors determining outcome. The subdivision of patients by clinical or demographic basis, although this proved to be increasingly difficult with increasing disability of the patients, and largely ceased when features is a familiar approach and is easily done, although it lacks established biological meaning.
they became bed-bound. Efforts were made to follow them up in nursing homes where possible, although this was We report a comparison of the long-term outcome in familial and sporadic multiple sclerosis based on a large usually restricted to a single occasion. It was possible to trace the great majority of these patients at the most recent population-based sample in which we search for heterogeneity in outcome. Observations of this population have been systematic follow-up in 1997, although some of the highest disability levels had to be determined by history for the most reported previously with respect to short-and intermediateterm outcome up to 1984 (Weinshenker et al., 1990) . For disabled patients. Almost a third of the patients had died by the time of this final evaluation. patients with familial and sporadic multiple sclerosis derived from the same population-based sample, we report here an During the nearly three decades of the clinic's operation, patients have been routinely and serially asked about the evaluation of the long-term clinical outcome up to 1997. Long-term observations provide three clear advantages in occurrence of multiple sclerosis among their family members. At the time of the last systematic global follow-up between such a comparison. Since multiple sclerosis has a relatively discrete age of onset curve, in which risk is strongly related the years 1995 and 1997, all surviving patients were again questioned about the existence of multiple sclerosis in their to age, the recognition of familial and non-familial cases becomes much more definitive with time, and the recurrence families. This was of doubtful value in those who had lost cognitive function to a degree that made it difficult for them risk for colineal relatives requires little or no correction for age. In addition, long-term survival curves of populations to comply, and was of low yield and/or unverifiable in those who had little or no contact with their families. Accordingly, destined to differ in outcome have had the opportunity to diverge, thereby enhancing the opportunity to show familial rates reported were certain to be underestimated to some extent, the more so for the more distant relatives. differences. Finally, disability outcomes in the long term are advanced, unambiguous and of undeniable clinical relevance.
A more detailed description of the general methods used in following this population has been described elsewhere In this population, more than half of the patients were confined to bed or chair, or were dead. (Weinshenker et al., 1990; Cottrell et al., 1999a) . For the purposes of this study, however, patients reporting an affected The observations reported here serve the following purposes: (i) they establish the frequency of familial multiple family member were asked for further documentation (i.e. records), with the consent of such a member when this was sclerosis in a large population base; (ii) they test the hypothesis that familial multiple sclerosis is different possible. For patients or affected relatives who had died, medical records were obtained. Affected relatives were also phenotypically from sporadic disease; (iii) they document the clinical outcome for familial multiple sclerosis in this seen frequently at the clinic, although they were only rarely part of the 1044 patient cohort, most often because they were population-based sample; and (iv) they test the validity of age-correction of empirical recurrence risks in families by seen before or after the accrual period of 1972-84, or lived elsewhere. identifying actual rates of recurrence in relatives of both sporadic and familial cases.
As in other papers in this series, a separate analysis was performed for the Middlesex County cohort, a restricted epidemiological subgroup (Hader et al., 1988) with high ascertainment and almost complete follow-up. At 25 years,
Methods
only seven out of the 203 patients in this subgroup were untraceable. The low rate of out-migration of area families
Study population
From 1972 to 1984, a cohort of 1099 consecutive patients was helpful. Pedigree size and age of relatives were identified for all probands. was followed at the multiple sclerosis clinic at University Campus, London Health Sciences Centre, London, Ontario.
The diagnostic criteria were those of Poser and colleagues (Poser et al., 1983) . Other heredofamilial disorders, especially With continued follow-up now reaching a mean of 25 years, the long-term natural history of multiple sclerosis in this system degenerations commonly confused with multiple sclerosis, are seen on a weekly basis in the multiple sclerosis population continues to be described (Cottrell et al., 1999a, b; Kremenchutzky et al., 1999) . From the original cohort, clinic. A low threshold for recognizing such disorders has existed since the early days of operation of the clinic. In an 1044 patients were evaluated for outcome. Some 55 patients were excluded for the following reasons: (i) 15 duplicates early study on multiple sclerosis sib-pairs, we restricted analysis to those having at least one affected individual with were not recognized initially because of name changes; and as right-censored. The log-rank statistic was used to test the χ 2 ϭ 4.10; P ϭ 0.66.
significance of the equality of survival distributions.
optic neuritis, internuclear ophthalmoplegia or oligoclonal
Results
banding in the CSF (Ebers et al., 1982) , but we did not demand this from patients in this series since diagnostic
Demographic characteristics
The demographic characteristics of the four subgroups of ambiguities were pointedly resolved as a background for collecting natural history data. multiple sclerosis patients derived from the original cohort are summarized in Table 1 . Eight hundred and thirty-six The total multiple sclerosis population was somewhat arbitrarily divided into the following categories, as previously patients had sporadic disease and 208 had familial multiple sclerosis according to the definitions which have been described (Weinshenker et al., 1990) : (i) sporadic multiple sclerosis: no affected relatives identified; (ii) first degree: a outlined. There was a relative excess of males in the firstdegree group and even greater excess in the first-degree plus single affected first-degree relative; (iii) first degree plus: multiple affected relatives including at least one first-degree group, although this fell short of statistical significance. The mean age of onset was similar among the four groups, as relative, as previously described; (iv) second or third degree: one or more affected second-or third-degree relatives.
was the mean duration of multiple sclerosis. Small numbers Primary progressive patients were excluded from this analysis. * P values are derived from χ 2 test;
† P values are derived from one-way ANOVA. Attack recurrence rate is defined as (number of patients with more than one attack)/(number of patients with at least one attack in the first year). For the second year, this parameter is defined as (number of patients with an attack in the first and second years)/(number of patients with at least one attack in the first year).
of patients in each group remained as possible cases. In all comparisons or when survival curves are compared for all familial cases versus all sporadic cases (Fig. 2) . Next we groups, these were patients in whom follow-up was truncated by death or loss to follow-up. The Middlesex County cohort compared patients with the clinical phenotypes of RR and PP disease between and among familial groups. Survival enjoyed a 97% follow-up rate (mean 25.9 Ϯ 8.6 years) and only one patient remained 'probable'.
curves for time to DSS 3, 6, 8 and 10 for (i) familial RR versus sporadic RR, and (ii) familial PP versus sporadic PP were derived (the data are not shown but are available from author G.C.E.). Little difference was noted among these
Initial presentation and clinical course
The initial symptom(s) among the four groups did not differ pairwise comparisons. The number of patients for each comparison and the P values for differences between them substantially. Optic neuritis was somewhat more common among the first-degree plus group but not more common are given in Table 5 . when the first-degree group was compared with the second-/ third-degree subgroup ( Table 2 ). The relative frequencies of clinical course were also rather similar among the different
Middlesex County cohort
In the Middlesex County cohort (n ϭ 203) there were 16 groups subclassified as having primary progressive (PP), secondary progressive (SP) and relapsing-remitting (RR) affected siblings among full brothers (mean age 56.23 years, range 31-95 years) and sisters (mean age 56.00 years, range multiple sclerosis, although the percentage of patients with primary progressive disease was slightly lower in the first 27-80 years) (total sibs, n ϭ 451) of clinic probands. This gives an observed recurrence risk of 3.5% and, with a slight degree plus subgroup (Table 3) . adjustment for remaining risk, suggests a final rate of~4.0%. The breakdown for this cohort among the four identified subgroups is given in Table 6 . The overall observed familial
Early relapse and disease progression
Following the initial exacerbation, the likelihood of relapse rate of 22.8% (Table 6 ) is slightly higher than the overall rate of 19.9% for the entire population, perhaps because in the first and second year of disease, the interval between the first and second attack and the time to onset of progressive of slightly better follow-up in this cooperative subgroup (Ebers, 1983) . deficit in those patients with secondary progressive disease were identified for each of the four subgroups (Table 4) . The likelihood of a second attack in the first 2 years was lower in the primary plus subgroup, the interval between the first
Discussion
We have examined long-term outcomes in 1044 multiple and second attack was greater, and there was a longer time to onset of progressive deficit in this group. These differences sclerosis patients from a largely population-based sample having a mean follow-up of 25 years. The extended clinical approach statistical significance or are of borderline significance (Table 4) only when correction for multiple follow-up of this population has allowed the evolution of widely diverging survivals for times to DSS 3, 6 and 8 and comparisons is forgone.
death from multiple sclerosis. Furthermore, at least for colineal relatives, much of the risk for being identified as having multiple sclerosis had elapsed. These factors should
Outcome
Initially we compared survival curves for each of the four have enhanced the ability to detect differences in outcome between familial and sporadic disease, a comparison which subgroups as given in Fig. 1 for times to DSS 3, 6, 8 and 10. Visually, these show little difference within any pair of was the primary focus of this study. The results establish a natural history for the~20% of patients identified as having from general multiple sclerosis population data (Sadovnick et al., 1988; Robertson et al., 1996a; Carton et al., 1997) . familial disease. These observations, from a sample in which detailed natural history observations have been made Given the relatively low concordance of age of onset in nontwin sibs with familial disease (Doolittle et al., 1990 ; Bulman previously, indicate that patients with familial disease have a clinical course which differs little from those whose disorder et al., 1991) it would be expected that population-based correction would suffice. However, the sib-pair data were remains sporadic even after several decades of follow-up. Accordingly, they provide little or no support for the based on smaller numbers, and it should be apparent that even in a study with a long follow-up there is potential for hypothesis that familial multiple sclerosis is a disorder distinct from the more common sporadic variety. ascertainment to bias results towards age of onset concordance. For example, it can be appreciated that The high familial rate identified in this study (22.8% in the Middlesex County cohort) supports the indications from concordant pairs with late onset in one member would tend to be under-represented. This problem would be most evident previous population-based studies in which relatively high familial risks were derived from age of onset curves compiled with short follow-up and the effect should wane with time, assuming similar likelihood of ascertainment over the period of their death may not have come until many years later. Since very few patients were lost to follow-up in Middlesex of observation. Examination of the Middlesex County cohort, in which long-term follow-up has been the most County, there was no bias or selection for familial multiple sclerosis, and these results should give the closest comprehensive, serves to specifically validate previous descriptions of recurrence risk for first-degree relatives approximation to the actual risks for sibs and for offspring. We have not attempted to ascertain the recurrence risks for derived from different populations within Canada. In this and three other Canadian sites, familial recurrence risks of parents, given the diagnostic difficulties inherent in going back one or two generations. The first neurologist in London, ജ20% have now been found (Hader, 1997; Sadovnick, 1988; T. J. Murray, personal communication) .
Ontario did not arrive until the early 1950s. Although several studies show that there are clinical, pathological and MRI We recognize limitations in the identification of familial rates. These are likely to be most accurate for the Middlesex features which are relatively different between PP, RR and SP multiple sclerosis (Thompson et al., 1997) , we found County subcohort. However, in patients who had long since died, the reporting of familial occurrence stopped at the time little correlation of phenotypes within multiple sclerosis families using this simple classification. The phenotype of of their last evaluation in the clinic, although the awareness n ϭ total number of patients in the analysis; P ϭ P value for the test of homogeneity of survival curves based on the log-rank statistic. Comparisons: (1) the four subgroups; (2) familial and sporadic multiple sclerosis; (3) familial RR and sporadic RR multiple sclerosis; and (4) familial PP and sporadic PP multiple sclerosis. The outcomes were examined in several ways, including
First/second degree 20 9.9 202 100.0 the comparison of all sporadic with all familial cases, and were similar. Such comparisons are weakly powered to show the index case had little or no influence on the phenotype of a difference when done early in the clinical course. Many the affected relative (Kremenchutzky et al., 1999) , confirming patients who are described as sporadic early on will eventually our earlier observations (Weinshenker et al., 1990) and have affected relatives. Similarly, benign or adverse outcomes subsequent observations from the UK (Robertson et al., identified in the early years of disease are only moderately 1996b). These findings establish observation-derived risks predictive and commonly change when viewed in long-term which are applicable at least to our Canadian population.
retrospect. Accordingly, we view these results at 25 years as The familial recurrence risks identified in this paper are being nearly definitive for the total group of familial versus likely to represent an underestimate, since ascertainment sporadic cases. Most patients in this study have reached the occurred most often through the reporting by multiple hard outcomes of DSS 6, and most of those who have not sclerosis clinic probands of the occurrence of affected may never do so. Many have gone to DSS 8 and 10 and the relatives (either in response to repeated surveys or comparative data for the familial versus the sporadic groups spontaneously). The independent ascertainment of relatives would appear to exclude only a small difference in clinical of other index cases within the London multiple sclerosis course. However, the power to address this question is clinic system has been frequent, and commonly this is probably not great among the four specific small subgroups unknown to the originally ascertained individual. We have of familial disease. We cannot exclude there being small observed that there remains a mean duration between clinical subgroups with clinical outcome which could differ materially onset and diagnosis of some 3-4 years, typically most evident from that of sporadic patients. Furthermore, we recognize in the later-onset cases (Cottrell et al., 1999a) , and we that our grouping of familial cases is somewhat arbitrary and estimate that, on average, an additional period of 4 years is unfounded in any known difference in pathogenesis. elapses between the diagnosis of the second member of a However, some modest trends support the observations that, family to be affected and the awareness of this by the first.
among individuals with a single affected parent and having Although this additional period is highly variable, these early age of onset, a higher familial risk combined with observations have implications for correction for age of onset earlier age of onset, on average, is present. These findings since this refinement makes the now unwarranted assumption support previous observations (Sadovnick et al., 1997) . that onset would be synonymous with recognition by all Families with high recurrence risks were found to have a previously affected family members.
lower age of onset in the proband (Sadovnick et al., 1998) . We have not corrected for doubly ascertained family This does not show up in the mean onset ages of our members. Recalculation of proband-wise concordance rates subgroups but is present when we used the divisions applied (recurrence risk) would elevate the observed crude risks.
by Sadovnick and colleagues (Sadovnick et al., 1998) (data This determination is problematic since the presence or not shown). A modestly more benign outcome of the first absence of complete ascertainment is a much more graded degree plus group early in the disease occurred in the presence determination in practice. Even in our strictest epidemiological sample, the Middlesex County population, of an excess of positive prognostic features. These included
